1,508
Views
40
CrossRef citations to date
0
Altmetric
Original Articles

Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses

, , , , , , , , , , , & show all
Pages 1-8 | Received 27 Aug 2017, Accepted 18 Nov 2017, Published online: 24 Jan 2018

References

  • BrasilPGuillain–Barre syndrome associated with Zika virus infectionLancet2016387 148210.1016/S0140-6736(16)30058-7
  • BautistaLESethiAKAssociation between Guillain–Barre syndrome and Zika virus infectionLancet20163872599 260010.1016/S0140-6736(16)30844-3
  • de OliveiraWKInfection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-5
  • CauchemezSAssociation between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective studyLancet20163872125213210.1016/S0140-6736(16)00651-64909533
  • MartinesRBPathology of congenital Zika syndrome in Brazil: a case seriesLancet201638889890410.1016/S0140-6736(16)30883-2
  • LuceyDCumminsHSholtsSCongenital Zika syndrome in 2017JAMA20173171368136910.1001/jama.2017.1553
  • MenesesJDALessons learned at the epicenter of Brazil’s congenital Zika epidemic: evidence from 87 confirmed casesClin. Infect. Dis.2017641302130810.1093/cid/cix166
  • Hurtado-Villa, P. et al. Raised frequency of central nervous system malformations related to Zika virus infection in two birth defects surveillance systems in Bogota and Cali, Colombia. Pediatr. Infect. Dis. J. https://doi.org/10.1097/INF.0000000000001670 (2017).
  • ReynoldsMRVital signs: update on Zika virus-associated birth defects and evaluation of all U.S. infants with congenital Zika virus exposure—U.S. Zika pregnancy registry, 2016Mmwr. Morb. Mortal. Wkly. Rep.20176636637310.15585/mmwr.mm6613e15657905
  • RatherIALoneJBBajpaiVKParkYHZika virus infection during pregnancy and congenital abnormalitiesFront. Microbiol.201785815875378815
  • AbbinkPProtective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeysScience20163531129113210.1126/science.aah61575237380
  • ShanCA live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse modelsNat. Med.20172376376710.1038/nm.4322
  • PardiNZika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNature201754324825110.1038/nature214285344708
  • RichnerJMModified mRNA vaccines protect against Zika virus infectionCell20171681114112510.1016/j.cell.2017.02.017
  • RichnerJMVaccine mediated protection against Zika virus-induced congenital diseaseCell201717027328310.1016/j.cell.2017.06.040
  • GriffinBDDNA vaccination protects mice against Zika virus-induced damage to the testesNat. Commun.2017810.1038/ncomms157435467228
  • KimEPreventative vaccines for Zika virus outbreak: preliminary evaluationEBioMedicine20161331532010.1016/j.ebiom.2016.09.0285264651
  • DittmerDPZika vaccine: clinical trial and error?Science2016353137510.1126/science.aai8117
  • MorrisonCDNA vaccines against Zika virus speed into clinical trialsNat. Rev. Drug. Discov.20161552152210.1038/nrd.2016.159
  • DyerOTrials of Zika vaccine are set to begin in North AmericaBMJ2016353i358810.1136/bmj.i3588
  • SirohiDThe 3.8 A resolution cryo-EM structure of Zika virusScience201635246747010.1126/science.aaf53164845755
  • MedinCLRothmanALZika virus: the agent and its biology, with relevance to pathologyArch. Pathol. Lab. Med.2017141334210.5858/arpa.2016-0409-RA
  • SapparapuGNeutralizing human antibodies prevent Zika virus replication and fetal disease in miceNature201654044344710.1038/nature205645583716
  • HasanSSA human antibody against Zika virus crosslinks the E protein to prevent infectionNat. Commun.2017810.1038/ncomms147225356071
  • DaiLStructures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibodyCell Host. Microbe20161969670410.1016/j.chom.2016.04.013
  • Tebas, P. et al. Safety and immunogenicity of an anti-Zika virus DNA vaccine—preliminary report. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1708120 (2017).
  • DuLZhouYJiangSThe latest advancements in Zika virus vaccine developmentExpert. Rev. Vaccin.20171695195410.1080/14760584.2017.1363648
  • StettlerKSpecificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionScience201635382382610.1126/science.aaf8505
  • DejnirattisaiWDengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virusNat. Immunol.2016171102110810.1038/ni.35154994874
  • PaulLMDengue virus antibodies enhance Zika virus infectionClin. Transl. Immunol.20165e11710.1038/cti.2016.72
  • WillisEHensleySECharacterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodiesVirology20175081610.1016/j.virol.2017.04.031
  • TaiWRecombinant receptor-binding domains of multiple Middle East respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutantsJ. Virol.201791e016511610.1128/JVI.01651-16
  • DuLIntroduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccinesNat. Commun.2016710.1038/ncomms134735121417
  • MaCSearching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—the importance of immunofocusing in subunit vaccine designVaccine2014326170617610.1016/j.vaccine.2014.08.0864194190
  • TaiWA recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infectionVirology201649937538210.1016/j.virol.2016.10.0055167628
  • ZhaoHStructural basis of Zika virus-specific antibody protectionCell20161661016102710.1016/j.cell.2016.07.0204983199
  • DuLIntranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infectionJ. Immunol.200818094895610.4049/jimmunol.180.2.9482603051
  • YuYA peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetusesNat. Commun.2017810.1038/ncomms156725537589
  • MeloASCongenital Zika virus infection: beyond neonatal microcephalyJAMA Neurol.2016731407141610.1001/jamaneurol.2016.3720
  • LaroccaRAVaccine protection against Zika virus from BrazilNature201653647447810.1038/nature189525003703
  • DowdKARapid development of a DNA vaccine for Zika virusScience201635423724010.1126/science.aai91375304212